| Adjusted hazard ratio | 95% confidence interval | P value |
---|---|---|---|
Male | 2.75 | 0.55 –13.79 | 0.218 |
Age | 1.07 | 0.99 – 1.15 | 0.103 |
Comorbidity | Â | Â | Â |
 Human immunodeficiency virus infection | - | - | - |
 Chronic obstructive pulmonary disease | - | - | - |
 Connective tissue disease | 0.33 | 0.04- 2.78 | 0.309 |
 Silicosis | - | - | - |
 Diabetes mellitus | 2.81 | 0.62 – 12.75 | 0.180 |
 End stage renal disease | - | - | - |
 Malignancy | 1.78 | 0.20 – 15.69 | 0.602 |
Liver disease | Â | Â | Â |
 Non-alcoholic liver cirrhosis | 0.97 | 0.11–8.46 | 0.976 |
 Alcoholic liver cirrhosis | - | - | - |
 Other alcoholic liver disease | - | - | - |
Liver disease severity | Â | Â | Â |
 Ascites | - | - | - |
 Esophageal varices | - | - | - |
 Hepatic encephalopathy | 54.90 | 2.82–1069.53 | *0.008 |
Interferon-based therapy | 2.81 | 0.61–12.98 | 0.185 |